Myriad Genetics reported $48M in Cost of Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Accelerate Diagnostics AXDX:US 2.16M 5K
Agilent A:US $ 746M 18M
Becton, Dickinson and BDX:US $ 2574M 132M
Bio Rad Laboratories BIO:US $ 295.12M 1.38M
Biocept BIOC:US $ 10.34M 0.3M
Bruker BRKR:US $ 290.2M 1.5M
Danaher DHR:US $ 3030M 47M
Exact Sciences EXAS:US $ 144.6M 9.9M
Fluidigm FLDM:US $ 28.7M 14.43M
Hologic HOLX:US $ 443.7M 45.4M
Illumina ILMN:US $ 408M 26M
Johnson & Johnson JNJ:US $ 7919M 321M
Mettler Toledo International MTD:US 406.73M 28.52M
Nanostring Technologies NSTG:US $ 15.85M 1.07M
Orasure Technologies OSUR:US $ 52.65M 9.21M
Pacific Biosciences Of California PACB:US $ 19.27M 0.26M
Perkinelmer PKI:US $ 563.41M 16.8M
Quest Diagnostics DGX:US $ 1611M 32M
Repligen RGEN:US $ 86.26M 3.9M
Thermo Fisher Scientific TMO:US $ 6240M 114M
Veracyte VCYT:US $ 25.03M 1.32M
Waters WAT:US $ 307.21M 21.52M